The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
| dc.contributor.author | Di Benedetto, Anna | |
| dc.contributor.author | Mottolese, Marcella | |
| dc.contributor.author | Sperati, Francesca | |
| dc.contributor.author | Ercolani, Cristiana | |
| dc.contributor.author | Di Lauro, Luigi | |
| dc.contributor.author | Pizzuti, Laura | |
| dc.contributor.author | Vici, Patrizia | |
| dc.contributor.author | Terrenato, Irene | |
| dc.contributor.author | Sperduti, Isabella | |
| dc.contributor.author | Shaaban, Abeer M | |
| dc.contributor.author | Sundara-Rajan, Sreekumar | |
| dc.contributor.author | Barba, Maddalena | |
| dc.contributor.author | Speirs, Valerie | |
| dc.contributor.author | De Maria, Ruggero | |
| dc.contributor.author | Maugeri-Saccà, Marcello | |
| dc.date.accessioned | 2018-07-20T15:48:06Z | |
| dc.date.available | 2018-07-20T15:48:06Z | |
| dc.date.issued | 2016-07-12 | |
| dc.description | This study was supported by the “Associazione Italiana per la Ricerca sul Cancro” (AIRC IG Grant N:13431 to RDM), and by Breast Cancer Now (formerly Breast Cancer Campaign; grant 2007MayPR02 to VS and AMS), which provided funding for the accrual and construction of the MBC TMAs described. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 11 | |
| dc.format.extent | 4326020 | |
| dc.identifier | 129546843 | |
| dc.identifier | 1cf32514-0f8d-4431-aff5-1a9dc14f3b3d | |
| dc.identifier | 27248471 | |
| dc.identifier | 84978633507 | |
| dc.identifier.citation | Di Benedetto, A, Mottolese, M, Sperati, F, Ercolani, C, Di Lauro, L, Pizzuti, L, Vici, P, Terrenato, I, Sperduti, I, Shaaban, A M, Sundara-Rajan, S, Barba, M, Speirs, V, De Maria, R & Maugeri-Saccà, M 2016, 'The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer', Oncotarget, vol. 7, no. 28, pp. 43188-43198. https://doi.org/10.18632/oncotarget.9668 | en |
| dc.identifier.doi | 10.18632/oncotarget.9668 | |
| dc.identifier.iss | 28 | en |
| dc.identifier.other | PubMedCentral: PMC5190017 | |
| dc.identifier.other | ORCID: /0000-0002-0602-4666/work/72631250 | |
| dc.identifier.uri | http://hdl.handle.net/2164/10775 | |
| dc.identifier.vol | 7 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Oncotarget | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Adaptor Proteins, Signal Transducing | en |
| dc.subject | Adult | en |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Breast Neoplasms, Male | en |
| dc.subject | Carcinogenesis | en |
| dc.subject | Carcinoma, Ductal, Breast | en |
| dc.subject | Connective Tissue Growth Factor | en |
| dc.subject | Gene Expression Regulation, Neoplastic | en |
| dc.subject | Humans | en |
| dc.subject | Immunohistochemistry | en |
| dc.subject | Intracellular Signaling Peptides and Proteins | en |
| dc.subject | Kaplan-Meier Estimate | en |
| dc.subject | Ki-67 Antigen | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Neoplasm Grading | en |
| dc.subject | Phenotype | en |
| dc.subject | Phosphoproteins | en |
| dc.subject | Proportional Hazards Models | en |
| dc.subject | Protein-Serine-Threonine Kinases | en |
| dc.subject | Rare Diseases | en |
| dc.subject | Receptors, Steroid | en |
| dc.subject | Retrospective Studies | en |
| dc.subject | Signal Transduction | en |
| dc.subject | Tissue Array Analysis | en |
| dc.subject | Journal Article | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer | en |
| dc.type | Journal article | en |
